Steve B

Steve is the lead editor of HighPeptides. He spends his evenings working through PubMed abstracts, FDA filings, and clinical trial registries — then translates that material into the plain-English research guides you find across this site. Every page is reviewed and revised by him as new evidence is published.

What Steve writes about

• Peptides — BPC-157, TB-500, GHK-Cu, thymosin, melanotan, and other research compounds.
• GLP-1 agonists — semaglutide, tirzepatide, retatrutide, and the broader incretin pipeline.
• SARMs — RAD-140, LGD-4033, MK-677, ostarine, and combinations.
• Nootropics — racetams, choline sources, dihexa, cerebrolysin.
• Hormones & longevity — TRT bloodwork, bioregulators, rapamycin, NAD+ precursors.

Editorial standards

• All compound research is sourced from PubMed-indexed literature, FDA filings, or clinical trial registries.
• Affiliate relationships are disclosed on every page that contains an affiliate link.
• Limitations of evidence are stated plainly — animal-only data is labeled as such.
• Guides are reviewed and updated as new research becomes available.
• HighPeptides does not provide medical advice. Educational use only.

Disclosure

"Steve B" is the editorial pen name used for HighPeptides. The image above is a stylized illustration, not a photograph. The research, citations, and editorial standards on this site are real — see our about page for the full publishing approach and affiliate disclosure.